ATAI - Company ID 0001840904
The table below shows ATAI Life Sciences N.V.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Revenue | $749.00K | $719.00K | $1.55M | $40.00K | $273.00K | $0.00 |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
ATAI Life Sciences N.V. reported annual revenue of $308.00K for fiscal year 2024. That is down 1.9% from $314.00K in fiscal 2023. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $14.51M |
| $14.90M |
| $10.60M |
| $10.27M |
| $13.40M |
| $12.55M |
| Operating income | -$28.44M | -$25.27M | -$20.37M | -$22.60M | -$25.73M | -$24.09M |
| Income tax | $131.00K | $93.00K | $156.00K | -$178.00K | $19.00K | -$4.00K |
| Net income | -$61.07M | -$27.73M | -$26.43M | -$26.29M | -$57.31M | -$26.71M |
| EPS (diluted) | -$0.28 | -$0.14 | -$0.15 | -$0.16 | -$0.36 | -$0.17 |